Feb 28 |
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript
|
Feb 27 |
BioCryst Pharmaceuticals files for a mixed securities shelf
|
Feb 27 |
BioCryst's Revenue Gains Offset By Rising Expenses: A Closer Look
|
Feb 27 |
BioCryst Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
|
Feb 27 |
Q4 2023 BioCryst Pharmaceuticals Inc Earnings Call
|
Feb 26 |
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
|
Feb 26 |
BioCryst Pharmaceuticals, Inc. (BCRX) Q4 2023 Earnings Call Transcript
|
Feb 26 |
BioCryst Pharmaceuticals (BCRX) Reports Q4 Loss, Tops Revenue Estimates
|
Feb 26 |
BioCryst Pharmaceuticals Inc (BCRX) Reports Growth in ORLADEYO Revenue and Projects ...
|
Feb 26 |
BioCryst Pharmaceuticals reports Q4 results
|